SR ONE

sr-one-logo

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.

#SimilarOrganizations #People #Financial #More

SR ONE

Social Links:

Industry:
Finance Financial Services Health Care Venture Capital

Founded:
1985-01-01

Status:
Active

Contact:
(610) 567-1000

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Content Delivery Network LetsEncrypt Amazon SSL By Default HSTS Nginx


Similar Organizations

alexandria-venture-investments-logo

Alexandria Venture Investments

Alexandria Venture Investments is a venture capital firm that develops the work in real estate technology, and healthcare sectors.

100x-ventures-logo

100x Ventures

100x Ventures is the corporate venture capital arm of 100x Group

caffeinated-capital-logo

Caffeinated Capital

Caffeinated Capital is a technology venture capital firm that partners with founders at the inception stage.

foundation-capital-logo

Foundation Capital

Foundation Capital is a venture capital firm made up of former entrepreneurs and helps companies and businesses grow.

general-catalyst-logo

General Catalyst

General Catalyst is a venture capital firm that provides early-stage and growth equity investments.

highland-capital-partners-logo

Highland Capital Partners

Highland Capital Partners is a venture capital firm that offers seed, early, and growth-stage funding solutions.

nexus-venture-partners-logo

Nexus Venture Partners

Nexus Venture Partners is a venture capital firm established by ex-entrepreneurs in enterprise technology and consumer internet.

pfizer-venture-investments-logo

Pfizer Venture Investments

Pfizer Venture Investments is a venture capital firm.

union-square-ventures-logo

Union Square Ventures

Union Square Ventures is a venture capital firm that focuses on early-stage, growth-capital, late-stage, and startup financing.

vivo-capital-logo

Vivo Capital

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

Current Employees Featured

jens-eckstein_image

Jens Eckstein
Jens Eckstein President @ SR One
President
2011-10-01

matthew-foy_image

Matthew Foy
Matthew Foy Partner @ SR One
Partner
2011-06-01

karen-narolewski-engel_image

Karen Narolewski Engel
Karen Narolewski Engel Partner @ SR One
Partner
2002-01-01

karen-narolewski-engel_image

Karen Narolewski Engel
Karen Narolewski Engel Vice President Operations @ SR One
Vice President Operations
2020-09-01

deborah-harland_image

Deborah Harland
Deborah Harland Venture Partner @ SR One
Venture Partner
2020-09-01

christopher-y-chai_image

Christopher Y. Chai
Christopher Y. Chai Venture Partner @ SR One
Venture Partner
2021-01-01

rajeev-dadoo_image

Rajeev Dadoo
Rajeev Dadoo Partner @ SR One
Partner
2004-01-01

shaun-foy_image

Shaun Foy
Shaun Foy Venture Partner @ SR One
Venture Partner
2017-05-01

jill-carroll_image

Jill Carroll
Jill Carroll Partner @ SR One
Partner
2011-09-01

simeon-george_image

Simeon George
Simeon George Chief Executive Officer @ SR One
Chief Executive Officer
2020-09-01

Investments List

Date Company Article Money raised
2024-07-17 Renalys Pharma SR One investment in Series A - Renalys Pharma 6 B JPY
2024-07-16 Asceneuron SR One investment in Series C - Asceneuron 100 M USD
2024-06-27 Kala Pharmaceuticals SR One investment in Post-IPO Equity - Kala Pharmaceuticals 12.5 M USD
2024-05-07 Zenas BioPharma SR One investment in Series C - Zenas BioPharma 200 M USD
2024-03-25 Nkarta Therapeutics SR One investment in Post-IPO Equity - Nkarta Therapeutics 240 M USD
2024-03-14 MISSION Therapeutics SR One investment in Series D - MISSION Therapeutics 25.2 M GBP
2024-03-06 Alumis SR One investment in Series C - Alumis 259 M USD
2024-02-13 CRISPR Therapeutics SR One investment in Post-IPO Equity - CRISPR Therapeutics 280 M USD
2023-12-05 Odyssey Therapeutics SR One investment in Series C - Odyssey Therapeutics 101 M USD
2023-09-27 Avalyn Pharma SR One investment in Series C - Avalyn Pharma 175 M USD

More informations about "SR One"

SR One - Crunchbase Company Profile & Funding

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science โ€ฆSee details»

SR One - Profiles & Contacts - Crunchbase

SR One is the corporate venture capital arm of GlaxoSmithKline.See details»

Find Care for Aging Parents | Senior.One

Now itโ€™s all in one place and I was able to find the perfect care plan for my parents.โ€ - Terry B. โ€œThe organization within the dashboard is outstanding โ€“ Iโ€™m able to track โ€ฆSee details»

Briana Wilson - SR One

Briana joined SR One in 2023 and is based in the San Francisco Bay Area office. Briana provides administrative support for various team members within the โ€ฆSee details»

SR One - Angel Investor Profile - raizer.app

SR One is the corporate venture capital arm of GlaxoSmithKline.See details»

Senior Leadership and Board | Hydro One

Before joining Hydro One, Mr. Lebeter held progressively senior positions in operations and safety at BC Hydro from 2005 to 2019, contributing to โ€ฆSee details»

Frances Benson - SR One

Frances joined SR One in 2020 and is based in the San Francisco Bay Area office. Frances manages several aspects of the firm's business functions including โ€ฆSee details»

Chris Chai - SR One

Biotech companies go through numerous transformative events including pre-clinical to clinical, privately held to publicly traded, and importantly R&D to a commercial organization. We are โ€ฆSee details»

SR One - campfire.wiki

SR One Capital Management is an American venture capital firm with offices in California, Pennsylvania and England.See details»

Team - SR One

For over a decade, our transatlantic team has brought a tried and tested partnership model to every relationship, showing how โ€ฆSee details»

SR One - Financial Details - Crunchbase

Exits. SR One's most notable exits include Alumis, ARS Pharmaceuticals, and Zenas BioPharma. Which industries has this organization had the most exits in? ShowSee details»

SR One - mtec-sc.org

SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. With a transatlantic presence, SR One focuses on โ€ฆSee details»

Sr Manager, Municipal Relations Job Details | Hydro One Networks Inc

Jul 31, 2025 Initiate programs to earn community respect and confidence. Monitor and analyze the community and public environment to determine requirements for communication and โ€ฆSee details»

Matthew R. Patterson - SR One

He also served as a member of the Board of Directors of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and โ€ฆSee details»

SR One Capital Management Overview - SignalHire

Summary SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an โ€ฆSee details»

SR One - Funding, Financials, Valuation & Investors - Crunchbase

Mar 27, 2023 SR One is the corporate venture capital arm of GlaxoSmithKline.See details»

SR One Capital Management - LinkedIn

SR One Capital Management | 4,357 followers on LinkedIn. Trans-Atlantic Biotech Investing | SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with โ€ฆSee details»

News - SR One

03/27/2023 SR One Closes Second Venture Fund at $600M 02/14/2023 Mineralys Therapeutics prices $221M IPO 01/20/2023 ADARx Pharmaceuticals raises $46M in Series B-1 and appoints โ€ฆSee details»

SR ONE CAPITAL MANAGEMENT, LP - WhaleWisdom.com

SR ONE Capital Management is based out of Wayne. SR ONE Capital Management is a hedge fund with 17 clients and discretionary assets under management (AUM) of $2,090,103,590 (Form ADV โ€ฆSee details»

Scientific Research and Experimental Development (SR&ED) tax

Jan 31, 2025 The Scientific Research and Experimental Development (SR&ED) tax incentive program lets Canadian businesses earn tax incentives that can reduce their income tax payable.See details»

linkstock.net © 2022. All rights reserved